With Over 65 Vendors and Counting, There’s Always New Ways to Save

Seqirus, part of the CSL Group, is the new global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis. In July 2015, the two businesses joined forces to create Seqirus, now the second-largest influenza vaccine company in the world. With extensive research and production expertise and manufacturing plants in the US, UK, Germany, and Australia, Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.

Click here to view their website.